We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader. Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
Patient Enrollment Resumed in the Investigator-initiated Phase 1/2 Clinical Trial of Seclidemstat in Combination with Azacitidine to Treat Hematologic Cancers Company Implemented Significant...
Company implementing a series of cost-savings measures designed to extend Salariusโ expected cash runway into the first half of 2025 Extended runway supports the generation of additional data...
Expands IP portfolio with composition-of-matter protection into 2039 for novel molecular glues Protein degrader portfolio now includes 17 issued patents across six patent families HOUSTON, Jan...
HOUSTON, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) announces that the hematologic cancer Phase 1/2 clinical trial being conducted at the University of Texas...
FDA briefing included new Ewing sarcoma clinical data from ongoing investigation where 60% of first-relapse patients achieved disease control and have not progressed after at least 14.5, 19.7 and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.001 | 0.2 | 0.5 | 0.5432 | 0.4652 | 32667 | 0.52395567 | CS |
4 | 0.0205 | 4.26638917794 | 0.4805 | 0.56 | 0.455 | 29467 | 0.50324599 | CS |
12 | -0.059 | -10.5357142857 | 0.56 | 0.7888 | 0.43 | 119884 | 0.53595054 | CS |
26 | -0.259 | -34.0789473684 | 0.76 | 0.93 | 0.43 | 73767 | 0.56501313 | CS |
52 | -1.269 | -71.6949152542 | 1.77 | 2.31 | 0.43 | 79056 | 0.95778572 | CS |
156 | -31.249 | -98.4220472441 | 31.75 | 37.75 | 0.43 | 502709 | 17.05454786 | CS |
260 | -288.249 | -99.8264935065 | 288.75 | 370.385 | 0.43 | 570925 | 28.60047085 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions